CaliciX™ - 60 capsules

Cats suffering from calicivirus may show:

• Severe gum inflammation

• Painful mouth ulcers on the tongue, gums, or cheeks

• Excessive drooling

• Bad breath

• Difficulty eating or swallowing

• Reduced appetite and weight loss
  
  These calicivirus symptoms can worsen over time, especially in chronic or recurrent cases.

Each CaliciX™ capsule contains 15 mg of EIDD-1931, the active antiviral form of molnupiravir, formulated specifically for cats.

Unlike supportive care alone, CaliciX™ works by:

• Targeting feline calicivirus replication

• Reducing viral activity at the source

• Supporting healing of oral tissues

This makes CaliciX™ a targeted option for calicivirus cats treatment, particularly when oral disease is persistent or recurrent.

CaliciX™ may be used under veterinary guidance to support cats diagnosed with:

• Feline Chronic Gingivostomatitis (FCGS)

• Juvenile gingivitis

• Caudal stomatitis

• Viral mouth ulcers

• Glossitis associated with calicivirus

Many cat parents report improvements in comfort, appetite, and overall quality of life when StomatiCure™ is included in a veterinarian-guided treatment plan.

✔ Designed specifically for feline calicivirus

✔ Contains EIDD-1931, not human molnupiravir

✔ Targets the viral cause, not just symptoms

✔ Supports long-term management of calici symptoms

If your cat suffers from calicivirus cat symptoms or recurring oral pain related to feline calicivirus, CaliciX™ offers a modern antiviral approach built specifically for feline needs.

Dosage may be adjusted by a licensed veterinarian based on the cat’s clinical response.

Signs that may indicate insufficient dosage include:

• Persistent drooling
• Pain or discomfort while chewing
• Slow healing of oral ulcers
• Unintended weight loss

Any dosage increase should remain within the recommended range and must be performed only under veterinary direction.

Use under veterinary supervision. Dosage and treatment duration may vary based on the severity of FCV in cats and clinical response.